Response to Trametinib of a Pulmonary Langerhans Cell Histiocytosis Harboring a MAP2K1 Deletion

被引：26
|
作者：
Lorillon, Gwenael [1 ]
Jouenne, Fanelie [1 ,2 ]
Baroudjian, Barouyr [1 ]
de Margerie-Mellon, Constance [1 ,2 ]
Vercellino, Laetitia [1 ]
Meignin, Veronique [1 ,3 ]
Lebbe, Celeste [1 ,2 ,4 ]
Vassallo, Robert [5 ]
Mourah, Samia [1 ,2 ,4 ]
Tazi, Abdellatif [1 ,2 ,6 ]
机构：
[1] AP HP, Paris, France
[2] Univ Paris Diderot, Paris, France
[3] INSERM, UMR S1165, Paris, France
[4] INSERM, U976, Paris, France
[5] Mayo Clin, Rochester, MN USA
[6] CRESS, U1153, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 198卷 / 05期
关键词：
ERDHEIM-CHESTER DISEASE; MUTATIONS; VEMURAFENIB; ACTIVATION;
D O I：
10.1164/rccm.201802-0275LE
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：675 / 678
页数：4
相关论文
共 50 条
  • [1] MAP2K1 and MAP3K1 Mutations in Langerhans Cell Histiocytosis
    Nelson, David S.
    van Halteren, Astrid
    Quispel, Willemijn T.
    van den Bos, Cor
    Bovee, Judith V. M. G.
    Patel, Bhumi
    Badalian-Very, Gayane
    van Hummelen, Paul
    Ducar, Matthew
    Lin, Ling
    MacConaill, Laura E.
    Egeler, R. Maarten
    Rollins, Barrett J.
    GENES CHROMOSOMES & CANCER, 2015, 54 (06): : 361 - 368
  • [2] High Prevalence of Somatic MAP2K1 Mutations in Langerhans Cell Histiocytosis
    Brown, N. A.
    Furtado, L. V.
    Betz, B. L.
    Kield, M. J.
    Weigelin, H. C.
    Lim, M. S.
    Elenitoba-Johnson, K. S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 713 - 714
  • [3] Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan
    Tomomi Hayase
    Shiori Saito
    Yoko Shioda
    Toshihiko Imamura
    Kenichiro Watanabe
    Kentaro Ohki
    Takako Yoshioka
    Yukiko Oh
    Yuta Kawahara
    Hitomi Niijima
    Shinsaku Imashuku
    Akira Morimoto
    International Journal of Hematology, 2020, 112 : 560 - 567
  • [4] BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases
    Alayed, Khaled
    Medeiros, L. Jeffrey
    Patel, Keyur P.
    Zuo, Zhuang
    Li, Shaoying
    Verma, Shalini
    Galbincea, John
    Cason, R. Craig
    Luthra, Rajyalakshmi
    Yin, C. Cameron
    HUMAN PATHOLOGY, 2016, 52 : 61 - 67
  • [5] Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan
    Hayase, Tomomi
    Saito, Shiori
    Shioda, Yoko
    Imamura, Toshihiko
    Watanabe, Kenichiro
    Ohki, Kentaro
    Yoshioka, Takako
    Oh, Yukiko
    Kawahara, Yuta
    Niijima, Hitomi
    Imashuku, Shinsaku
    Morimoto, Akira
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (04) : 560 - 567
  • [6] Analysis of the BRAF and MAP2K1 Mutations in Patients with Langerhans Cell Histiocytosis in Japan
    Hayase, Tomomi
    Shioda, Yoko
    Imamura, Toshihiko
    Watanabe, Kenichiro
    Ohki, Kentaro
    Yoshioka, Takako
    Oh, Yukiko
    Kawahara, Yuta
    Imasyuku, Shinsaku
    Morimoto, Akira
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [7] Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis
    Azorsa, David O.
    Lee, David W.
    Wai, Daniel H.
    Bista, Ranjan
    Patel, Apurvi R.
    Aleem, Eiman
    Henry, Michael M.
    Arceci, Robert J.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (09)
  • [8] Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations
    Pina-Oviedo, Sergio
    Medeiros, L. Jeffrey
    Li, Shaoying
    Khoury, Joseph D.
    Patel, Keyur P.
    Alayed, Khaled
    Cason, R. Craig
    Bowman, Christopher J.
    Yin, C. Cameron
    MODERN PATHOLOGY, 2017, 30 (05) : 734 - 744
  • [9] BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children
    Zeng, Kaixuan
    Ohshima, Koichi
    Liu, Yixiong
    Zhang, Weichen
    Wang, Lu
    Fan, Linni
    Li, Mingyang
    Li, Xia
    Wang, Zhe
    Guo, Shuangping
    Yan, Qingguo
    Guo, Ying
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 845 - 851
  • [10] GENOTYPING OF BRAF WILD-TYPE LANGERHANS CELL HISTIOCYTOSIS AND IDENTIFICATION OF A NOVEL MAP2K1 INDEL
    Singh, Preeti
    Milne, Paul
    Bacon, Chris
    Cuthbert, Gavin
    Bomken, Simon
    Visser, Johann
    PEDIATRIC BLOOD & CANCER, 2021, 68
12345